Thus, it is possible that ATGL‐mediated SIRT1 activation could be responsible for abolishing G0S2‐mediated apoptosis in scenarios when it is highly expressed (e.g., CP‐CML). This evidence concerns the gene PNPLA2 and chronic myelogenous leukemia, BCR-ABL1 positive.